Search results
AbbVie Is 'Firing On All Cylinders,' But Its Stock Isn't
Investor's Business Daily· 2 days agoShares tumbled despite a first-quarter beat and earnings guidance increase.
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 3 days agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
AbbVie Reports First-Quarter 2024 Financial Results
Tri-County Times· 3 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...
Investing.com· 3 days agoAbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
AbbVie announces LEVEL UP results in atopic dermatitis study By Investing.com
Investing.com· 3 days agoThe study focused on adult and adolescent patients who had an inadequate response to systemic...
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: U.S. Humira sales fell 40% year over year during the first three months of 2024, to...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 6 days agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
AbbVie: Q1 Earnings Snapshot - WTOP News
WTOP Washington· 3 days agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter earnings of $1.37 billion. On a per-share basis, the North Chicago…
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 6 days agoWe have seen a stock pullback here in April, and three of these high-quality dividend paying stocks...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 3 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...